Corporate, News, Santé
Déménagement de notre bureau à Paris
Date de publication : 19/03/21

The H2020-funded SiMBiT (Grant No 824946) project aims to develop a disruptive in-vivo testing solution that can perform single-molecule detection of both proteins and DNA bio-markers.
The SiMBiT cost-effective platform exhibits enhanced sensing capabilities: specificity towards both genomic and protein markers along with single-molecule detection limits, and time-to results within two hours. This makes the SiMBiT prototype the world best performing bio-electronic sensing system.
In a consortium of 9 European partners coordinated by CSGI, In Extenso Innovation Croissance (through its subsidiary Efficient Innovation) brings its expertise in Innovation Management and also coordinates dissemination & exploitation activities.
Visit https://simbit-h2020.eu/ to learn more about the project
Corporate, News, Santé
Déménagement de notre bureau à Paris
News
#Classement, #Sustainability
[RANKINGS] « Energie & Environnement – RSE » : catégorie “Excellent”
News
#Marque Employeur
In Extenso Innovation Croissance certifié Great Place to Work
Innovation, News
#Classement
[RANKINGS] Décideurs Magazine confirme l’excellence de nos expertises en innovation
Événements, News
WEBINAR – Funding innovation: new opportunities from the French government’s recovery plan
News
#Marque Employeur
Un cabinet de conseil où il fait bon travailler !